Skip to main content
Clinical Trials/PACTR202401852393337
PACTR202401852393337
Recruiting
Phase 4

Analgesia Nociceptive Index for Nociception Monitoring in Cirrhotic Patients Undergoing Hepatic Resection: Randomized Control Trial

national liver institute0 sites40 target enrollmentDecember 14, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
national liver institute
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.cirrhotic patients candidate for hepatic resection
  • 2\. Child classification (A)

Exclusion Criteria

  • 1\.patients suffered from Major intraoperative events (e.g. severe hemodynamic instability, massive blood loss, .
  • 2\. Allergic patients to any of the study drugs, Opioid addiction,
  • 3\. Body\-mass index higher than 40 kg/m²and
  • 4\. when ANI measurement cannot be interpreted arrhythmia, pace maker (certain types) heart transplant drugs affecting the sinus node (atropine and other anticholinergic drugs,

Outcomes

Primary Outcomes

Not specified

Similar Trials